Navigation Links
Joint Replacement Patients Face Blood Clot Risk in Hospital
Date:1/17/2012

By Denise Mann
HealthDay Reporter

TUESDAY, Jan. 17 (HealthDay News) -- One of every 100 people undergoing knee replacement surgery and 1 of 200 people having hip replacement surgery will develop a blood clot before they leave the hospital, even if they take steps to prevent the development of these blood clots, a new evidence review suggests.

A deep venous thrombosis (DVT) or blood clot can form deep within the veins, usually in the leg. The real risk occurs if these blood clots dislodge, travel through your bloodstream, and block blood flow in your lungs, which is called pulmonary embolism.

The new study, published in the Jan. 18 Journal of the American Medical Association, seeks to provide a reliable benchmark of this risk, but many experts in the field worry that the actual risk of blood clots after joint replacement is really much higher than this study suggests.

Researchers led by Jean-Marie Januel, of the Lausanne University Hospital, in Switzerland, analyzed 47 studies comprising nearly 45,000 joint replacement cases. All patients received preventive measures to lower their risk of developing a blood clot. Despite this treatment, one in every 100 patients undergoing knee replacement and 1 in every 200 patients undergoing hip replacement developed a blood clot before hospital discharge. Prevention typically involves getting patients moving soon after surgery, providing compression stockings or boots and administering some type of medication that prevents clots from forming.

Dr. John Heit, a cardiologist at the Mayo Clinic in Rochester, Minn., wrote an editorial accompanying the new report.

"The authors are trying to estimate the magnitude of the problem among patients who receive the most effective prophylaxis available today," Heit said. But the risk is actually much higher than the study suggests, he said. "One has to understand the period of risk extends beyond the duration of hospitalization, which these days, is really quite short."

He added, "Orthopedic surgeons are very aware of this problem and do an excellent job in choosing patients that are most likely to benefit from surgery, and they are very religious in terms of providing some form of prophylaxis after surgery."

Dr. Joel Buchalter, an orthopedic surgeon at Somers Orthopaedic Surgery and Sports Medicine Group in Carmel, N.Y., agreed. He said that the risk of blood clots after joint replacement surgery may be even higher. The new study looked only at patients who developed blood clots in the hospital, but these blood clots can develop weeks after the surgery, he said.

Signs of a blood clot may include swelling, tenderness and pain when flexing the ankle, Buchalter said. "If a person has any of these symptoms, an ultrasound exam can rule a blood clot in or out, but many times blood clots have no symptoms. Some people have a great-looking leg and have a blood clot and don't even know it," he said.

Dr. Mathias Bostrom, an orthopedic surgeon at the Hospital for Special Surgery in New York City, said that the risk for blood clots after a joint replacement is real. "The new study once again reinforces that even in 2012, the risk of blood clots after total knee or hip replacement surgery is significant," Bostrom said. There are many new drugs available today to help lower risk for blood clots after surgery, but these do have risks of their own, he said.

More information

Learn more about deep vein thrombosis at the American Academy of Orthopaedic Surgeons.

SOURCES: John Heit, M.D., cardiologist, Mayo Clinic, Rochester, Minn.; Mathias Bostrom, M.D., orthopedic surgeon, Hospital for Special Surgery, New York City; Joel Scott Buchalter, M.D., orthopedic surgeon, Somers Orthopaedic Surgery and Sports Medicine Group, Carmel, N.Y.; Jan. 18, 2012, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. ATS issues joint statement on key issues and recommendations for critical care research
2. Timing of Aquatic Therapy After Joint Replacement Matters
3. AIUM and AUA develop joint guideline for the performance of an ultrasound examination in urology
4. Patients at risk of knee joint complications when new technology is used
5. Titanium Joint Debris May Trigger Painful Inflammation
6. Study helps eliminate causes for joint pain linked to commonly used breast cancer drugs
7. Studies Suggest Link Between Smog, Joint Disease
8. A new definition for periprosthetic joint infection
9. Race Tied to Risk for Arthritis in Large Joints
10. Joint preservation in osteoarthritis
11. More African-Americans burdened by osteoarthritis in multiple large joints
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Joint Replacement Patients Face Blood Clot Risk in Hospital
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: